EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Unhealthy visceral fat is associated with improved efficacy of immunotherapy in endometrial cancer

Matthew L Steinhauser

Journal of Clinical Investigation · 03.09.2024 · 134 (17)

DOI: 10.1172/jci183675 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 03.09.2024. Verfasst von Matthew L Steinhauser. Beteiligte Einrichtung: Center for Human Integrative Physiology, Aging Institute, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA. Hauptthemen laut MEDLINE: Endometrial Neoplasms, Intra-Abdominal Fat. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Obesity is a known driver of endometrial cancer. In this issue of the JCI, Gómez-Banoy and colleagues investigated a cohort of patients with advanced endometrial cancer treated with immune checkpoint inhibitors targeting the interaction between programmed cell death receptor-1 (PD-1) and its ligand (PD-L1). Notably, a BMI in the overweight or obese range was paradoxically associated with improved progression-free and overall survival. A second paradox emerged from CT analyses of visceral adipose tissue, viewed as an unhealthy fat depot in most other contexts, the quantity of which was also associated with improved treatment outcomes. Though visceral adiposity may have value as a biomarker to inform personalized treatment strategies, of even greater impact would be if a therapeutic strategy emerges from the future identification of adipose-derived mediators of this putative anticancer immune-priming effect.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endometrial NeoplasmsIntra-Abdominal FatHumansFemaleImmunotherapyImmune Checkpoint InhibitorsObesityProgrammed Cell Death 1 Receptor

Substanzen

Immune Checkpoint InhibitorsProgrammed Cell Death 1 ReceptorPDCD1 protein, human

Autor:innen und Institutionen

  • Center for Human Integrative Physiology, Aging Institute, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
  • Division of Cardiovascular Medicine, Department of Medicine, University of Pittsburgh Medical Center and School of Medicine, Pittsburgh, Pennsylvania, USA.

Zitieren

APA

Steinhauser, M. L. (2024). Unhealthy visceral fat is associated with improved efficacy of immunotherapy in endometrial cancer. Journal of Clinical Investigation, 134(17). https://doi.org/10.1172/jci183675

Vancouver

Steinhauser ML. Unhealthy visceral fat is associated with improved efficacy of immunotherapy in endometrial cancer. Journal of Clinical Investigation. 2024;134(17). doi:10.1172/jci183675

BibTeX
@article{Steinhauser2024,
  author = {Steinhauser, Matthew L},
  title = {Unhealthy visceral fat is associated with improved efficacy of immunotherapy in endometrial cancer},
  journal = {Journal of Clinical Investigation},
  year = {2024},
  volume = {134},
  number = {17},
  doi = {10.1172/jci183675}
}
Kostenlos starten →